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INTRODUCTION: 
In recent years, fungal infections are on the rise due to 
various predisposing factors such as long term 
administration of antibiotics, use of steroids, pulmonary 
tuberculosis, immunosuppressive drugs and HIV 
infection1. Candida species are one of the potentially 
pathogenic fungal agents in patients with broncho-
pulmonary disease. They are associated with secondary 
infections in tuberculosis patients2. When host resistance 
is lowered, these unrecognized opportunistic fungi may 
affect the progress of disease or may even become fatal1, 
3. Hence, there is need to consider the possible 
importance of these saprophytic organisms when they are 
found repeatedly and evidently from the site of the 
lesion4.   Candida albicans (C. albicans) was considered 
the most important pathogen causing secondary infection 
in pulmonary tuberculosis5. C. albicans stimulated 
growth of M. tuberculosis of reduced viability6. Another 
study confirmed the effect of polysaccharide fraction of 
C.albicans for enhancement of the growth as well as 
reduction of the generation time of tubercle bacilli6. But 
in recent times, there is increase in incidence of non-
albicans Candida infection6. Most of the non- albicans 
Candida usually exhibit a reduced susceptibility to the 
common antifungal agents5. Hence identification of 
Candida to the species level has become mandatory to 
aid the selection of appropriate antifungal agents in 
treatment of invasive candidiasis. Identification of 
Candida species by conventional methods is a 
cumbersome and time consuming process. Usage of 
chromogenic medium could be a substitute to 
conventional identification techniques for rapid 
identification of Candida spp. 
 
ABSTRACT 
Introduction: In recent years, fungal infections are on the rise due to various predisposing factors such as long term 
administration of antibiotics, use of steroids, pulmonary tuberculosis, immunosuppressive drugs and HIV infection. When 
host resistance is lowered, these opportunistic fungi may become fatal. Candida albicans was the most important pathogen 
causing pulmonary candidiasis. In recent times, there is increase in incidence of non-albicans Candida. Identification to the 
species level becomes mandatory in the selection of appropriate antifungal agents. Aim: To find out the prevalence of 
Candida co-infection among pulmonary tuberculosis patients and to identify the species of Candida using CHROMagar. 
Materials & Methods: A total of 107 smear positive pulmonary tuberculosis patients were included in this study. Two 
consecutive sputum samples were collected and subjected to gram staining. Only those samples which showed pus cells with 
budding yeast cells and pseudohyphae in direct gram stain were cultured on Sabouraud’s dextrose agar (SDA) with 
gentamycin. The Candida grown was identified and speciated based on the color produced on CHROMagar Candida. Results: 
Out of 21 Candida isolates, 14 were C. albicans (66.7%), 2 were C. tropicalis (9.5%), 2 were C.krusei (9.5%), 2 were C. 
parapsilosis (9.5%) and one was C. glabrata (4.8%). Conclusion: The secondary fungal infections are associated with 
persistence of lung symptoms inspite of successful completion of antituberculous therapy. Hence adequate measures need to 
be taken for the early identification and treatment of these opportunistic infections.  
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Aim: 
The present study was undertaken to find out the 
prevalence of Candida co-infection among pulmonary 
tuberculosis patients in Salem district and to identify the 
species of Candida using CHROMagar. 
MATERIALS & METHODS: 
A total of 107 smear positive pulmonary tuberculosis 
patients were included in this study done during June- 
September 2013 in Vinayaka Mission’s Kirupananda 
Variyar Medical College, Salem. The study was done 
after obtaining informed consent from the patients and 
instituitional ethical committee clearance. Two 
consecutive sputum samples were collected from each 
patient and subjected to gram staining and culture. A 
detailed history regarding smoking, alcohol 
consumption, calorie intake etc., was collected from the 
patients by administering a questionairre. The criteria for 
diagnosis of candidiasis were based on the presence of 
pus cells with budding yeast cells and pseudohyphae in 
direct gram stain1. Only those samples which satisfied 
this criterion were subjected to culture on Sabouraud’s 
dextrose agar (SDA) with gentamycin. The samples 
which showed only budding yeast cells without 
pseudohyphae were excluded from the study. The 
Candida grown on SDA was speciated by inoculating 
onto CHROMagar Candida. After inoculation onto 
CHROMagar, the plates were incubated for 48 hours at 
37◦C and the colonies were identified based on the color 
produced by the Candida species. Light green colonies- 
Candida albicans, blue colonies with pink halo - 
Candida tropicalis, purple colonies- Candida glabrata, 
pink colonies- Candida krusei, cream colonies- Candida 
parapsilosis. 
RESULTS:  
Out of 107 sputum positive pulmonary tuberculosis 
patients, Candida coinfection was observed in 19 
patients (17.7%). Among these 19 samples, two samples 
showed dual infection (with two different species of 
Candida in same sample). Hence total number of 
Candida isolated was 21.  
Candida albicans was the predominant species causing 
secondary infection. Out of 21 Candida isolates, 14 were 
identified as C. albicans (66.7%), 2 were C. tropicalis 
(9.5%), 2 were C. krusei (9.5%) and C. parapsilosis was 
also isolated from 2 cases (9.5%). C. glabrata was 
isolated from one sample (4.8%).  
Table 1: Species distribution of Candida (n=21) 
S.No Fungal species No of isolates 
1 Candida albicans 14(66.7%) 
2 Candida tropicalis 2(9.5%) 
3 Candida krusei 2(9.5%) 
4 Candida parapsilosis 2(9.5%) 
5 Candida glabrata 1(4.8%) 
 
C.albicans was the predominant species causing co-
infection among pulmonary tuberculosis patients in our 
study.
 
Table 2: Distribution of Candida infection based on DOTS category 
S.No Fungal species DOTS category Total 
category 1(74) category 2(32) XDR TB(1) 
1 Candida albicans 8 5 1 14 
2 Candida tropicalis 2 0 0 2 
3 Candida krusei 1 1 0 2 
4 Candida parapsilosis 1 1 0 2 
5 Candida glabrata 1 0 0 1 
 Total 13(17.57%) 7(21.87%) 1 21 
P value= 0.687 
Statistically, the isolation of Candida was independent of the Category of the disease as shown in table 2. 
 
Table 3: Distribution of Candida infection in different gender & among alcoholics 
 Fungal infection Gender Alcohol 
Males Females Alcoholics Non- alcoholics 
Candida species(n=21) 12(57.14%) 9(42.86%) 11(52.38%) 10(47.62%) 
P value for gender= 0.634 
P value for alcohol= 0.723 
 
There is no gender specific prevalence of fungal infections among TB patients. The secondary Candida infection is also 
not related to alcohol consumption in our study as shown in table 3. 
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Table 4: Distribution of Candida infection among 
smokers 
S. 
No. 
Smoking No of Candida isolated (n=21) 
1 Smokers 15 (71.43%) 
2 Non-smokers 6 (28.57%) 
P value <.005 
In our study, smoking was significantly associated with 
incidence of Candida infection among tuberculous 
patients. This was found to be statistically significant.  
Table 5: Distribution of Candida infection based on 
BMI 
S. No 
Body Mass 
Index 
No of Candida isolated 
(n=21) 
1 < 15 4 (19.04%) 
2 15-18 12 (57.14%) 
3 18.1-21 3 (14.28%) 
4 21.1-24 2 (9.52%) 
P <.005 
Prevalence of fungal infection is more common in 
patients having low BMI when compared to those with 
normal or high BMI and this difference was found to be 
statistically significant.  
DISCUSSION: 
The present study shows 18% of pulmonary tuberculosis 
patients to be co-infected with Candida spp. This is in 
accordance with the study done by Sehar Afshan Naz 
and Perween Tariq6 in which 15.2% of co-infection with 
Candida species was documented. But this is low when 
compared to the study of VP Baradkar et al1 which 
shows a prevalence of 26 % co-infection with Candida 
species. Candida forms a part of normal microbial flora 
of healthy individuals. When the host resistance is 
lowered, these commensals turn into aggressive 
pathogens causing life threatening systemic infections. 
The role of Candida species as secondary invaders in 
patients having pre-existing diseases like pulmonary 
tuberculosis is well documented6.   
Among the Candida spp, C. albicans was the commonest 
organism causing secondary infection in our study. C. 
albicans constituted 66.7% of the total Candida isolates. 
This correlates with the study conducted by Kali A et al2 
which also demonstrates C. albicans to be the 
commonest species causing secondary infection 
comprising 50% of the total Candida isolates. 
Although C. albicans was the commonest species 
causing secondary infection, other non-albicans Candida 
species were also associated with secondary infection in 
our study. The non-albicans Candida isolated were C. 
tropicalis (9.5%), C.krusei (9.5%), C. parapsilosis 
(9.5%) and C. glabrata (4.8%). This is similar to the 
study of Latha et al5 which also showed increased 
incidence of non-albicans Candida infection. 
Our study revealed that the CHROM agar was very 
useful in rapid identification of Candida species. The 
media was very sensitive in identifying most of the 
species like C albicans, C.tropicalis, C.glabrata, C. 
parapsilosis and C.krusie. It was also highly useful in 
identifying dual infections. The colony morphology and 
the colour of the colony were consistent for over a period 
of 4-5 days. Hence determination of colour was simple 
and not cumbersome. This finding correlated with other 
studies using chromogenic medium5. Early identification 
of Candida species aids in early appropriate treatment 
thereby reducing the morbidity and mortality in these 
patients7.    
Coexistence of Candida and tuberculosis is well 
documented since a long time8. These Candida 
infections, when associated with pre-existing disease, 
may cause many complications in the primary disease. It 
has also been observed that secondary fungal infections 
in the lungs of pulmonary tuberculous patients are 
associated with marked cough, expectoration, dyspnea 
and fever6. 
Weak immune status, destruction of lung tissues and 
lesions formed due to TB are the predisposing factors for 
fungal infections9. Prolonged treatment with antibiotics 
and corticosteroids also makes these patients more prone 
for opportunistic infections10. This is very well 
documented in our study which shows candida infection 
is more common among smokers and those with low 
Body Mass Index (BMI). 
Though C. albicans seems to be the commonest 
pathogen associated with pulmonary candidiasis, there is 
also increase in the incidence of non- albicans Candida. 
Among non-albicans Candida species, C. tropicalis has 
been emerging as a new opportunistic pathogen to cause 
severe invasive disease. C. tropicalis has an apparently 
greater capacity than C.albicans to invade the deep 
tissues of immunocompromised host6.  
Hence adequate measures should be taken for the 
prevention and treatment of these opportunistic 
infections in tuberculous patients. Options of antifungal 
drugs available to treat chronic candidiasis infections are 
limited; moreover resistance to the available drugs may 
result in failure of treatment9. Identification of Candida 
to the species level has become mandatory for selecting 
the appropriate antifungal agents in treatment of invasive 
candidiasis because most of the non albicans Candida 
exhibit reduced fluconazole susceptibility5. 
CONCLUSION: 
C. albicans continues to be the commonest pathogen 
responsible for pulmonary Candidiasis. Smoking and low 
BMI are the factors determining the prevalence of fungal 
infection among our study population. The secondary 
fungal infections in lungs of tuberculous patients are 
associated with persistence of lung symptoms inspite of 
successful completion of antituberculous therapy. Hence 
adequate measures need to be taken for the early 
identification and treatment of these opportunistic 
infections. In addition, identification to the species level 
becomes mandatory in selecting the appropriate 
antifungal agents. 
  
Mathavi et al                                         Journal of Drug Delivery & Therapeutics; 2014, 4(3), 118-121 121 
© 2011-14, JDDT. All Rights Reserved                                                 ISSN: 2250-1177                                               CODEN (USA): JDDTAO 
REFERENCES: 
1. Baradkar VP, Mathur M, Wanjari K and Kumar S. Candida in 
Pulmonary Tuberculosis. Bombay Hospital Journal, Special 
Issue, 2009; 52-53. 
2. Kali A, Charles MP, Noyal MJ, Sivaraman U, Kumar S and 
Easow JM. Prevalence of Candida co-infection in patients 
with pulmonary tuberculosis. Australas Med J 2013; 6(8): 
387-91. 
3. Khanna BK, Nath P and Ansari AH. A study of mycotic flora 
of respiratory tract in pulmonary tuberculosis. Ind J Tuberc 
1977; 24: 159-62. 
4. Jain SK, Agrawal RL, Pandey RC, Agrawal M and Sharma S. 
A clinico-radiological study of secondary mycoses in 
pulmonary tuberculosis. Ind J Med Sci 1991; 45:81-84. 
5. Latha R et al. Study on the shifting patterns of Non Candida 
albicans Candida in lower respiratory tract infections and 
evaluation of the CHROMagar in identification of the 
Candida species. J Microbiol Biotech Res 2011; 1(3): 113-
119. 
6. Sehar Afshan Naz and Perween Tariq. A study of the trend in 
prevalence of opportunistic candidal co-infections among 
patients of pulmonary tuberculosis. Pak. J. Bot 2004; 4: 857-
862. 
7. Agarwal S, Manchanda V, Verma N and Bhalla P. Yeast 
identification in routine clinical microbiology laboratory and 
its clinical relevance. Indian Journal of Medical Microbiology 
2011; 29(2): 172-177. 
8. Longo LB, Harbuck AB and Fleischmann W. Coexistence of 
fungi and Tubercle Bacilli. Dis Chest 1958; 33:398-400. 
9. Rathod VS, Raut JS and Mohan Karuppayil S. Antifungal 
Drug Susceptibility of Candida albicans isolates from 
pulmonary tuberculosis patients. Int J Pharm Pharm Sci 2012; 
Vol 4, Suppl 5: 323-326. 
10. Phukan AC, Sarmabordoloi JN and Mahanta J. 
Bronchopulmonary Candidiasis in a tertiary referral hospital 
of Assam, India. Ind J Med Sci 2000; 54: 491-494.
 
 
